Particularly Partial-body CryostimulationNCT06812819
Effect of Cryostimulation on Selected Motor Skills in Soccer Players
A study testing Cryostimulation is a form of cooling the body using low temperatures without causing tissue damage. The stimulus effect is achieved at temperatures below - 110⁰C, in a short time of 1-3 minutes. The p in people with Particularly Partial-body Cryostimulation, run by Poznan University of Physical Education at 1 site in Poland.
Trial summary
A randomized study was conducted during two training periods. The first stage of a 5-day cryostimulation procedure took place in November 2022, during the training period after the end of the league season. The second stage was conducted in January 2023, during the preparation period in full training loads. Read more about this study
- Who is it for?
- Ages 18 to 35 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Particularly Partial-body Cryostimulation
- What is being tested?
- Cryostimulation is a form of cooling the body using low temperatures without causing tissue damage. The stimulus effect is achieved at temperatures below - 110⁰C, in a short time of 1-3 minutes. The p
- How many people
- Not given
- Where
- 1 sitePoland
- Study dates
- Start not givento not given
- Phase
- Expanded access
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- TraAge: 18-35 years,
- Training: at least three years,
- regular training
- Health status: no musculoskeletal injuries,
- Medical certificate from a certified sports physician indicating readiness to participate in intensive training and cryostimulation treatments.
- Lifestyle restrictions:
Show all 19Show fewer
- agreement to refrain from additional regenerative therapies, cosmetic treatments, alcohol, stimulants and dietary supplements during the study.
- Inclusion Criteria:
- TraAge: 18-35 years,
- Training: at least three years, regular training
- Health status: no musculoskeletal injuries,
- Medical certificate from a certified sports physician indicating readiness to participate in intensive training and cryostimulation treatments.
- Lifestyle restrictions: restrictions on additional regenerative therapies, cosmetic procedures, alcohol, stimulants and dietary supplements during the study.
- Exclusion criteria:
- Age: under 18 or over 35 years of age,
- Training: less than three years of regular professional soccer training or playing.
- Health conditions: acute or chronic injuries, cardiovascular diseases, respiratory diseases or conditions that contraindicate cryostimulation,
- Failure to follow: planned training, testing or cryostimulation protocols; failure to follow lifestyle restrictions as outlined in the study guidelines,
- Contraindications to cryostimulation: sensitivity or adverse reactions to cold exposure.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
Poland1 site
Department of Physiotherapy, Poznań University of Physical Education, Faculty of Sport Sciences In Gorzów Wielkopolski; Poland
Gorzów Wielkopolski, Lubusz Voivodeship, 66-400
About this study
A randomized study was conducted during two training periods. The first stage of a 5-day cryostimulation procedure took place in November 2022, during the training period after the end of the league season. The second stage was conducted in January 2023, during the preparation period in full training loads. The sequence of procedures used in both stages was the same (fig. 1). Before the application of cryostimulation, both PBC and CON groups underwent measurements: anthropometric using Tanita BC-418 MA analyzer (Medizin \& Service GmbH, Germany), step frequency (tapping) and lower limb maximal power (jump with sweep, jump without sweep), Opto Gait optical system (MicroGate Timing and Sport, BONZAMO, Italy ). Athletes in the PBC group, at the same hours of 8: 00 (stage I) and 17:00 (stage II), were subjected daily to cryostimulation in a JUKA cryosauna (model 0104-1, Germany). Both PBC and CON groups participated in training together throughout the study period.
Read the detailed description
Anthropometric measurements Using Tanita BC-418 MA analyzer, (Medizin \& Service GmbH, Germany), measurement accuracy was ± 0.1 kg. The following parameters were analyzed: body mass index (BMI), total body water (TBW), fat mass (FM), and fat-free mass (FFM), and basal metabolism (BMR), Table 1. All measurements were taken fasting at 8:00 a.m. on the first and fifth day of the study in both groups of subjects. The device was calibrated before each testing session according to the manufacturer's guidelines.
Fitness tests Measurements of step frequency and maximal power [W/kg] of the lower limbs were performed using the OptoGait optical system (MicroGate Timing and Sport, BONZAMO, Italy). The measurement system consisted of two panels used to detect spatial parameters for gait, jumping, and reaction time. Measurement strips were placed in parallel on the ground at a distance of 1.5 meters from each other. The test consisted of 3 parts: tapping (step frequency), maximal jumping up without upper limb sweep, and maximal jump up with upper limb assisted sweep (analysis of lower limb maximal power and jump height). Test subjects were positioned between the slats in the starting position, and performed 3 test trials, each trial began and ended with an audible signal, and the time of a single trial was 10 seconds. Analysis of the components of lower limb maximal power and step frequency was performed in the PBC and CON groups on the first and last days of the study.
Cryostimulation (PBC) PBC protocol involved the participant being in a JUKA cryosauna (model 0104-1), for 3 minutes at - 140 ° C± - 20 ° C with the lid at shoulder height and the head over the chamber. The cryosauna was cooled with liquid nitrogen, and the temperature was monitored by a computer. Participants entered the cabin wearing clogs, wool socks, shorts, gloves, caps, and disposable PP non-woven masks to protect against inhalation of nitrogen fumes. The temperature inside the cryosauna was recorded at 30-second intervals using a sensor placed on the bottom of the cabin. The temperature of the room where the cryosauna was located was 21.0 ± 0.9° C, and the humidity of the air during the treatment was 35 ± 2, 0 % monitored with a QUIGG type LE 2014.14 moisture absorber. All participants received instructions on proper breathing and cryosauna behavior before the PBC procedure. They received information on risks, complications, and indications for immediate discontinuation of the therapy. Athletes signed an informed consent for the experiment. During the PBC, they remained in constant visual and auditory contact with the therapy supervisor. A cryostimulation session was performed every day from 8:00-9:00 am, for 5 days. During one PBC treatment, the athletes spent 3 minutes at -140° C ± 20° C. Each entry into the cryosauna was preceded by a measurement of saturation temperature and blood pressure. These measurements were taken again each day immediately after exiting the cryosauna. After completing the cryotherapy procedure, the athletes were subjected to a 15-minute warm-up according to a set schedule.
- Being tested
- Cryostimulation is a form of cooling the body using low temperatures without causing tissue damage. The stimulus effect is achieved at temperatures below - 110⁰C, in a short time of 1-3 minutes. The p
- Keywords
- cryotherapy, cold exposure, motor skills, soccer players, athletic recovery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cryostimulation is a form of cooling the body using low temperatures without causing tissue damage. The stimulus effect is achieved at temperatures below - 110⁰C, in a short time of 1-3 minutes. The pDiagnostic test
Also called OptoGait optical system (MicroGate Timing and Sport, BONZAMO, Italy, Tanita BC-418 MA analyzer, (Medizin & Service GmbH, Germany, JUKA cryosauna 0104-1, Germany
PBC protocol involved the participant being in a JUKA cryosauna (model 0104-1), for 3 minutes at - 140 ° C± - 20 ° C with the lid at shoulder height and the head over the chamber. The cryosauna was cooled with liquid nitrogen, and the temperature was monitored by a computer. Participants entered the cabin wearing clogs, wool socks, shorts, gloves, caps, and disposable PP non-woven masks to protect against inhalation of nitrogen fumes. The temperature inside the cryosauna was recorded at 30-second intervals using a sensor placed on the bottom of the cabin. The temperature of the room where the cryosauna was located was 21.0 ± 0.9° C, and the humidity of the air during the treatment was 35 ± 2, 0 % monitored with a QUIGG type LE 2014.14 moisture absorber.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Particularly Partial-body CryostimulationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Expanded access
Sponsor and investigators
- Lead sponsor
- Poznan University of Physical Education
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Izabela Różycka, Poznan University of Physical Education
- Investigators
- Izabela Różycka, mgr, Principal investigator, Department of Physiotherapy, Poznań University of Physical Education, Faculty of Sport Sciences In Gorzów Wielkopolski; Poland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06812819
- Sponsor's protocol ID
- 12622001541796, ANZCTR
- Status last verified
- May 2025
- First submitted
- 31 Jan 2025
- Last updated
- 31 May 2025
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Cryostimulation on Selected Motor Skills in Soccer Players
- ClinicalTrials.gov ID
- NCT06812819
- Acronym / sponsor ID
- 12622001541796, ANZCTR
- Keywords
- cryotherapy, cold exposure, motor skills, soccer players, athletic recovery
- Study type
- Expanded access
- Recruitment status
- Approved For Marketing
- Lead sponsor
- Poznan University of Physical EducationUniversity, hospital or other
- First posted
- 6 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A randomized study was conducted during two training periods. The first stage of a 5-day cryostimulation procedure took place in November 2022, during the training period after the end of the league season. The second stage was conducted in January 2023, during the preparation period in full training loads. The sequence of procedures used in both stages was the same (fig. 1). Before the application of cryostimulation, both PBC and CON groups underwent measurements: anthropometric using Tanita BC-418 MA analyzer (Medizin \& Service GmbH, Germany), step frequency (tapping) and lower limb maximal power (jump with sweep, jump without sweep), Opto Gait optical system (MicroGate Timing and Sport, BONZAMO, Italy ). Athletes in the PBC group, at the same hours of 8: 00 (stage I) and 17:00 (stage II), were subjected daily to cryostimulation in a JUKA cryosauna (model 0104-1, Germany). Both PBC and CON groups participated in training together throughout the study period.
Detailed description
Anthropometric measurements Using Tanita BC-418 MA analyzer, (Medizin \& Service GmbH, Germany), measurement accuracy was ± 0.1 kg. The following parameters were analyzed: body mass index (BMI), total body water (TBW), fat mass (FM), and fat-free mass (FFM), and basal metabolism (BMR), Table 1. All measurements were taken fasting at 8:00 a.m. on the first and fifth day of the study in both groups of subjects. The device was calibrated before each testing session according to the manufacturer's guidelines.
Fitness tests Measurements of step frequency and maximal power [W/kg] of the lower limbs were performed using the OptoGait optical system (MicroGate Timing and Sport, BONZAMO, Italy). The measurement system consisted of two panels used to detect spatial parameters for gait, jumping, and reaction time. Measurement strips were placed in parallel on the ground at a distance of 1.5 meters from each other. The test consisted of 3 parts: tapping (step frequency), maximal jumping up without upper limb sweep, and maximal jump up with upper limb assisted sweep (analysis of lower limb maximal power and jump height). Test subjects were positioned between the slats in the starting position, and performed 3 test trials, each trial began and ended with an audible signal, and the time of a single trial was 10 seconds. Analysis of the components of lower limb maximal power and step frequency was performed in the PBC and CON groups on the first and last days of the study.
Cryostimulation (PBC) PBC protocol involved the participant being in a JUKA cryosauna (model 0104-1), for 3 minutes at - 140 ° C± - 20 ° C with the lid at shoulder height and the head over the chamber. The cryosauna was cooled with liquid nitrogen, and the temperature was monitored by a computer. Participants entered the cabin wearing clogs, wool socks, shorts, gloves, caps, and disposable PP non-woven masks to protect against inhalation of nitrogen fumes. The temperature inside the cryosauna was recorded at 30-second intervals using a sensor placed on the bottom of the cabin. The temperature of the room where the cryosauna was located was 21.0 ± 0.9° C, and the humidity of the air during the treatment was 35 ± 2, 0 % monitored with a QUIGG type LE 2014.14 moisture absorber. All participants received instructions on proper breathing and cryosauna behavior before the PBC procedure. They received information on risks, complications, and indications for immediate discontinuation of the therapy. Athletes signed an informed consent for the experiment. During the PBC, they remained in constant visual and auditory contact with the therapy supervisor. A cryostimulation session was performed every day from 8:00-9:00 am, for 5 days. During one PBC treatment, the athletes spent 3 minutes at -140° C ± 20° C. Each entry into the cryosauna was preceded by a measurement of saturation temperature and blood pressure. These measurements were taken again each day immediately after exiting the cryosauna. After completing the cryotherapy procedure, the athletes were subjected to a 15-minute warm-up according to a set schedule.
Study design
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (19 listed)
- TraAge: 18-35 years,
- Training: at least three years,
- regular training
- Health status: no musculoskeletal injuries,
- Medical certificate from a certified sports physician indicating readiness to participate in intensive training and cryostimulation treatments.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cryostimulation is a form of cooling the body using low temperatures without causing tissue damage. The stimulus effect is achieved at temperatures below - 110⁰C, in a short time of 1-3 minutes. The pAlso: OptoGait optical system (MicroGate Timing and Sport, BONZAMO, Italy, Tanita BC-418 MA analyzer, (Medizin & Service GmbH, Germany, JUKA cryosauna 0104-1, GermanyPBC protocol involved the participant being in a JUKA cryosauna (model 0104-1), for 3 minutes at - 140 ° C± - 20 ° C with the lid at shoulder height and the head over the chamber. The cryosauna was cooled with liquid nitrogen, and the temperature was monitored by a computer. Participants entered the cabin wearing clogs, wool socks, shorts, gloves, caps, and disposable PP non-woven masks to protect against inhalation of nitrogen fumes. The temperature inside the cryosauna was recorded at 30-second intervals using a sensor placed on the bottom of the cabin. The temperature of the room where the cryosauna was located was 21.0 ± 0.9° C, and the humidity of the air during the treatment was 35 ± 2, 0 % monitored with a QUIGG type LE 2014.14 moisture absorber. | Diagnostic test | – |
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 May 2025.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Izabela Różycka, mgr principal investigator
Department of Physiotherapy, Poznań University of Physical Education, Faculty of Sport Sciences In Gorzów Wielkopolski; Poland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cryostimulation is a form of cooling the body using low temperatures without causing tissue damage. The stimulus effect is achieved at temperatures below - 110⁰C, in a short time of 1-3 minutes. The p in people with Particularly Partial-body Cryostimulation, run by Poznan University of Physical Education at 1 site in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 19 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2025.